scholarly article | Q13442814 |
P50 | author | Ru-Rong Ji | Q42386007 |
P2093 | author name string | Jianren Mao | |
Grewo Lim | |||
Backil Sung | |||
P2860 | cites work | DNA fragmentation in granular cells of human cerebellum following global ischemia | Q70983125 |
A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum | Q73093466 | ||
NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity | Q73196404 | ||
Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons | Q73315891 | ||
Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats | Q73452402 | ||
Enzymatic degradation protects neurons from glutamate excitotoxicity | Q74146341 | ||
N -methyl- D -aspartate (NMDA) induced apoptosis in adult rabbit retinas | Q74338259 | ||
Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury | Q78060140 | ||
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process | Q28189431 | ||
Opioids induce while nicotine suppresses apoptosis in human lung cancer cells | Q28306814 | ||
Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain | Q28363748 | ||
A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior | Q28373340 | ||
Morphine promotes apoptosis in Jurkat cells | Q28374975 | ||
NeuN, a neuronal specific nuclear protein in vertebrates | Q28510657 | ||
Neuronal plasticity: increasing the gain in pain | Q29615421 | ||
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
Caspase inhibitors promote the survival of avulsed spinal motoneurons in neonatal rats. | Q32106420 | ||
Cell death in the superficial dorsal horn in a model of neuropathic pain | Q33181857 | ||
Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions | Q33679560 | ||
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes | Q33909931 | ||
Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression | Q34506808 | ||
Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse | Q35874052 | ||
Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons | Q36605145 | ||
Acute decrease in net glutamate uptake during energy deprivation. | Q36985138 | ||
Glutamate and the pathophysiology of hypoxic--ischemic brain damage | Q38161694 | ||
Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death | Q38308058 | ||
Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells. | Q39427768 | ||
Apoptosis in the Nervous System: Morphological Features, Methods, Pathology, and Prevention | Q40423446 | ||
kappa-Opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell line | Q40837210 | ||
Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. | Q41002806 | ||
Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. | Q41188027 | ||
The pharmacology and mechanism of action of riluzole | Q41263084 | ||
Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. | Q41652154 | ||
Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion | Q41732395 | ||
Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine | Q42287163 | ||
The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. | Q42547439 | ||
Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain. | Q42550229 | ||
Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions | Q43429365 | ||
Protection by NMDA antagonists against selective cell loss following transient ischaemia | Q43530761 | ||
Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy | Q43547058 | ||
Protein kinase C modulates NMDA receptor trafficking and gating | Q43558099 | ||
Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. | Q43581713 | ||
Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator | Q43604538 | ||
Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin. | Q43610828 | ||
Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal | Q43651505 | ||
The role of NMDA receptors in neonatal cocaine-induced neurotoxicity | Q43709804 | ||
Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice | Q43814056 | ||
NMDA receptor inhibition prevents tolerance to cocaine | Q43945488 | ||
The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids | Q44332822 | ||
Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. | Q44333127 | ||
Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid | Q44335232 | ||
Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation | Q44341541 | ||
Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens | Q44345874 | ||
Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. | Q44347824 | ||
Regulation of the glial glutamate transporter GLT-1 by glutamate and delta-opioid receptor stimulation | Q44348434 | ||
Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. | Q44352087 | ||
Mu-opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus. | Q44352563 | ||
Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury | Q44896954 | ||
The development of morphine tolerance and dependence is associated with translocation of protein kinase C. | Q45080390 | ||
Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine | Q45081186 | ||
Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. | Q45085836 | ||
Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy | Q45093137 | ||
Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine | Q46086009 | ||
Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion | Q46823137 | ||
Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat | Q46904809 | ||
Delayed application of MK-801 attenuates development of morphine tolerance in rats | Q46956859 | ||
Regional differences in the effects of glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid on extracellular amino acids and dopamine in rat brain: an in vivo microdialysis study | Q47691289 | ||
Protective effect of apoptosis-inhibitory agent, N-tosyl-L-phenylalanyl chloromethyl ketone against ischemia-induced hippocampal neuronal damage | Q47696892 | ||
Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis | Q48100781 | ||
Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization | Q48198206 | ||
Reciprocal changes in the expression of Bcl-2 and Bax in hypoglossal nucleus after axotomy in adult rats: possible involvement in the induction of neuronal cell death | Q48215639 | ||
Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
Phospholipase A2 modulates different subtypes of excitatory amino acid receptors: autoradiographic evidence | Q48392729 | ||
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo | Q48396095 | ||
Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons | Q48403884 | ||
Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation | Q48493712 | ||
Cocaine induces apoptosis in cortical neurons of fetal mice | Q48701879 | ||
Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor | Q48726529 | ||
Substrate turnover by transporters curtails synaptic glutamate transients | Q48906935 | ||
Enhancement of NMDA-induced functional responses without concomitant NMDA receptor changes following chronic ethanol exposure in cerebellar granule cells. | Q50514865 | ||
Prostaglandin E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. | Q50527322 | ||
The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. | Q50919908 | ||
Cocaine induces cell death within the primate fetal cerebral wall. | Q51423377 | ||
The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. | Q51591862 | ||
Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801 | Q52052445 | ||
Effects of bombesin on methadone-induced apoptosis of human lung cancer cells. | Q52277165 | ||
Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway. | Q55475246 | ||
NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia | Q56880509 | ||
Activation of apoptosis-linked caspase(s) in NMDA-injured brains in neonatal rats | Q58115481 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | morphine | Q81225 |
neurotoxicity | Q3338704 | ||
apoptotic process | Q14599311 | ||
opioid | Q427523 | ||
P304 | page(s) | 7650-7661 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism | |
P478 | volume | 22 |
Q37531862 | A new pharmacological role for donepezil: attenuation of morphine-induced tolerance and apoptosis in rat central nervous system |
Q88162637 | Adjunctive therapy for neonatal abstinence syndrome: why not personalize it for each infant based on their in-utero exposure? |
Q44396263 | Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. |
Q46294271 | An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional survey |
Q35149088 | Biphasic effect of curcumin on morphine tolerance: a preliminary evidence from cytokine/chemokine protein array analysis |
Q92857202 | Carbonyl-protein content increases in brain and blood of female rats after chronic oxycodone treatment |
Q86441455 | Changes of GTP cyclohydrolase I and neuronal apoptosis in rat spinal dorsal cord induced by sciatic nerve injury |
Q35764822 | Chronic Opium Treatment Can Differentially Induce Brain and Liver Cells Apoptosis in Diabetic and Non-diabetic Male and Female Rats |
Q37155946 | Chronic daily headache: transformational migraine, chronic migraine, and related disorders |
Q52297206 | Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing |
Q48228685 | Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain. |
Q51735904 | Chronic oxycodone induces axonal degeneration in rat brain. |
Q41774030 | Cocaine-Mediated Autophagy in Astrocytes Involves Sigma 1 Receptor, PI3K, mTOR, Atg5/7, Beclin-1 and Induces Type II Programed Cell Death |
Q35943702 | Deficit of circulating stem--progenitor cells in opiate addiction: a pilot study |
Q64075887 | Dexmedetomidine for the Management of Postoperative Pain and Sedation in Newborns |
Q42422393 | Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates |
Q34624598 | Do opioids induce hyperalgesia? |
Q39787535 | Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells |
Q46024266 | Effect of chronic administration of morphine on the gene expression level of sodium-dependent vitamin C transporters in rat hippocampus and lumbar spinal cord. |
Q28660034 | Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism |
Q37629247 | Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity |
Q89909001 | Electroacupuncture Alleviates Experimental Chronic Inflammatory Pain by Inhibiting Calcium Voltage-Gated Channel-Mediated Inflammation |
Q35581558 | Endogenous opiates and behavior: 2002 |
Q33231309 | Escalating management of progressive neuropathic cancer pain |
Q37227174 | Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury |
Q36092170 | Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers |
Q36389131 | Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors |
Q26740384 | From Drug-Induced Developmental Neuroapoptosis to Pediatric Anesthetic Neurotoxicity-Where Are We Now? |
Q46491990 | GLT-1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine. |
Q80852989 | Gaps and junctions between clinical experience and theoretical framework in the use of opioids |
Q34231164 | General anesthetics in pediatric anesthesia: influences on the developing brain |
Q28484293 | Global changes in the rat heart proteome induced by prolonged morphine treatment and withdrawal |
Q24806575 | Glutamate transporter: an unexpected target for some antibiotics |
Q24806246 | Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release |
Q80130959 | Impact of chronic nicotine on the development and maintenance of neuropathic hypersensitivity in the rat |
Q36590742 | In vivo morphine treatment synergistically increases LPS-induced caspase activity in immune organs |
Q26768068 | Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain |
Q39279068 | Intracerebroventricular administration of riluzole prevents morphine-induced apoptosis in the lumbar region of the rat spinal cord. |
Q80367537 | Loss of neurons from laminas I-III of the spinal dorsal horn is not required for development of tactile allodynia in the spared nerve injury model of neuropathic pain |
Q43236166 | Maternal oral consumption of morphine increases Bax/Bcl-2 ratio and caspase 3 activity during early neural system development in rat embryos |
Q37198850 | Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia |
Q42936784 | Minocycline prevents morphine-induced apoptosis in rat cerebral cortex and lumbar spinal cord: a possible mechanism for attenuating morphine tolerance. |
Q35579655 | Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment |
Q40037212 | Morphine Inhibited the Rat Neural Stem Cell Proliferation Rate by Increasing Neuro Steroid Genesis. |
Q64261647 | Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18 months |
Q36798747 | Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation |
Q41530211 | Morphine pre- and post-conditioning exacerbates apoptosis in rat hippocampus cells in a model of homocysteine-induced oxidative stress. |
Q48629661 | Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit |
Q36428066 | Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts |
Q52592793 | Morphine-alcohol treatment impairs cognitive functions and increases neuro-inflammatory responses in the medial prefrontal cortex of juvenile male rats. |
Q36807732 | Morphine-enhanced apoptosis in selective brain regions of neonatal rats |
Q48842409 | Morphine-induced apoptosis in the ventral tegmental area and hippocampus after the development but not extinction of reward-related behaviors in rats. |
Q39267599 | Neurobiological Effects of Morphine after Spinal Cord Injury |
Q42475582 | Neuropathological alterations in drug abusers : The involvement of neurons, glial, and vascular systems |
Q24681779 | Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment |
Q49270407 | Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System |
Q35582306 | Opioid Therapy for Chronic Pain |
Q38090368 | Opioid administration following spinal cord injury: implications for pain and locomotor recovery |
Q34613490 | Opioid induced hyperalgesia in anesthetic settings |
Q35044048 | Opioid resistance in chronic daily headache: a synthesis of ideas from the bench and bedside |
Q36405690 | Opioid-induced abnormal pain sensitivity |
Q44807834 | Opioid-induced hyperalgesia. Pathophysiology and clinical relevance |
Q37328701 | Peroxynitrite and opiate antinociceptive tolerance: a painful reality |
Q44341348 | Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation |
Q43811430 | Pre-operative opioid analgesia reduces clinical success of laparoscopic gastric electrical stimulation placement in patients with gastroparesis. |
Q33593295 | Prenatal morphine exposure reduces pyramidal neurons in CA1, CA2 and CA3 subfields of mice hippocampus |
Q39536727 | Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress |
Q91790243 | Protein Kinase A Is Involved in Neuropathic Pain by Activating the p38MAPK Pathway to Mediate Spinal Cord Cell Apoptosis |
Q36398092 | Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program |
Q36098677 | Purkinje cells loss in off spring due to maternal morphine sulfate exposure: a morphometric study |
Q42049607 | Recombinant human growth hormone improves cognitive capacity in a pain patient exposed to chronic opioids |
Q36734759 | Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures |
Q28568562 | Riluzole prevents morphine-induced apoptosis in rat cerebral cortex |
Q37293705 | Spinal expression of Hippo signaling components YAP and TAZ following peripheral nerve injury in rats |
Q42077528 | Stereological study of the effects of morphine consumption and abstinence on the number of the neurons and oligodendrocytes in medial prefrontal cortex of rats |
Q37849424 | Tetracyclines and pain |
Q59797210 | The Protective and Restorative Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Methadone-Induced Toxicity In Vitro |
Q41977639 | The impact of morphine after a spinal cord injury |
Q93113089 | The mitochondrial calcium uniporter contributes to morphine tolerance through pCREB and CPEB1 in rat spinal cord dorsal horn |
Q37907914 | The role of morphine in regulation of cancer cell growth |
Q37629272 | The role of the somatotrophic axis in neuroprotection and neuroregeneration of the addictive brain |
Q42639183 | Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice |
Q90299756 | Topical Ketamine with Other Adjuvants: Underutilized for Refractory Cancer Pain? A Case Series and Suggested Revision of the World Health Organization Stepladder for Cancer Pain |
Q62086883 | Update of the Scientific Opinion on opium alkaloids in poppy seeds |
Q33987944 | Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal rat |
Q36310086 | X Chromosome Inactivation in Opioid Addicted Women |
Search more.